Every record from PeptideMeter
Runs dual-wavelength detection as standard and reports named related substances rather than totals only. Measured offset against the reference laboratory is -0.024 pp on 569 paired lots. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043106 | Tirzepatide | KP | KP-2608-D5921 | 2026-Q3 | 98.90 | 5.45 | 105.4 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041767 | Semaglutide | FGP | FGP-2602-M1508 | 2026-Q3 | 98.65 | 2.54 | — | Supplier-supplied | 2 | FAIL |
| AX-2026-041741 | Tirzepatide | FGP | FGP-2603-L9714 | 2026-Q3 | 98.62 | 2.57 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041380 | BPC-157 | WWB | WWB-2606-H3906 | 2026-Q3 | 99.45 | 4.52 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041383 | BPC-157 | WWB | WWB-2606-H3906 | 2026-Q3 | 99.17 | 4.84 | 91.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043111 | Tirzepatide | KP | KP-2608-D5921 | 2026-Q3 | 99.71 | 5.15 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042194 | Retatrutide | Homopeptide | HOMO-2605-V9833 | 2026-Q3 | 98.90 | 4.07 | 98.8 | Supplier-supplied | 3 | MARGINAL |
| AX-2026-041936 | Semaglutide | TFC | TFC-2604-X4301 | 2026-Q3 | 98.62 | 4.30 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-041482 | PT-141 (Bremelanotide) | QYB | QYB-2607-L5615 | 2026-Q3 | 99.41 | 3.97 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041457 | Retatrutide | QYB | QYB-2604-B5660 | 2026-Q3 | 98.66 | 2.85 | 102.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042651 | Melanotan II | GGPeps | GGPE-2603-P8735 | 2026-Q3 | 99.53 | 7.04 | 90.7 | Supplier-supplied | 4 | MARGINAL |
| AX-2026-041730 | CJC-1295 with DAC | QSC | QSC-2602-E9474 | 2026-Q3 | 98.79 | 6.93 | 95.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042547 | Survodutide | ERP | ERP-2605-E7682 | 2026-Q3 | 98.25 | 5.44 | 93.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042739 | Selank | GGPeps | GGPE-2603-J9708 | 2026-Q3 | 99.03 | 9.09 | 102.1 | Supplier-supplied | 0 | PASS |
| AX-2026-043086 | Ipamorelin | KP | KP-2606-D5887 | 2026-Q3 | 98.74 | 3.45 | 91.6 | Supplier-supplied | 1 | FAIL |
| AX-2026-042215 | LL-37 | Homopeptide | HOMO-2602-G1280 | 2026-Q3 | 99.83 | 5.36 | 89.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041489 | PT-141 (Bremelanotide) | QYB | QYB-2607-L5615 | 2026-Q3 | 99.40 | 4.39 | 90.1 | Supplier-supplied | 0 | PASS |
| AX-2026-043502 | BPC-157 | BCH | BCH-2603-G6422 | 2026-Q3 | 97.72 | 4.86 | — | Buyer-sourced | 1 | FAIL |
| AX-2026-042238 | IGF-1 LR3 | Homopeptide | HOMO-2607-P1246 | 2026-Q3 | 98.34 | 6.38 | 95.0 | Laboratory-retained | 0 | PASS |
| AX-2026-041938 | Semaglutide | TFC | TFC-2604-X4301 | 2026-Q3 | 99.06 | 4.17 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041925 | TB-500 | JEEP | JEEP-2605-M4874 | 2026-Q3 | 99.93 | 2.15 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041958 | Tirzepatide | TFC | TFC-2605-G5134 | 2026-Q3 | 98.17 | 6.54 | 93.0 | Supplier-supplied | 3 | FAIL |
| AX-2026-042070 | SS-31 (Elamipretide) | TFC | TFC-2604-Y7472 | 2026-Q3 | 98.09 | 3.60 | 97.9 | Supplier-supplied | 1 | FAIL |
| AX-2026-041651 | Liraglutide | QSC | QSC-2605-W8602 | 2026-Q3 | 99.32 | 5.96 | — | Supplier-supplied | 2 | FAIL |
| AX-2026-043288 | L-Carnosine | CPC | CPC-2603-G1651 | 2026-Q3 | 99.03 | 9.94 | 105.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042273 | SLU-PP-332 | Homopeptide | HOMO-2602-Y2822 | 2026-Q3 | 99.81 | 4.60 | 88.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043501 | BPC-157 | BCH | BCH-2603-G6422 | 2026-Q3 | 98.37 | 4.75 | 100.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043202 | Semaglutide | GL Biochem | GLBI-2602-U8631 | 2026-Q3 | 96.77 | 6.38 | 89.7 | Supplier-supplied | 3 | FAIL |
| AX-2026-042236 | SS-31 (Elamipretide) | Homopeptide | HOMO-2604-D1599 | 2026-Q3 | 99.61 | 2.79 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042210 | LL-37 | Homopeptide | HOMO-2602-G1280 | 2026-Q3 | 99.36 | 5.23 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042543 | Tesamorelin | ERP | ERP-2604-W7280 | 2026-Q3 | 99.16 | 4.03 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041257 | Semaglutide | WWB | WWB-2602-M2472 | 2026-Q3 | 99.23 | 2.75 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041885 | Semaglutide | JEEP | JEEP-2607-X3911 | 2026-Q3 | 98.62 | 4.04 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043318 | Tirzepatide | CPC | CPC-2607-L2552 | 2026-Q3 | 96.58 | 5.20 | — | Supplier-supplied | 2 | FAIL |
| AX-2026-042576 | TB-500 | ERP | ERP-2605-S8022 | 2026-Q3 | 99.55 | 2.98 | 94.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041924 | TB-500 | JEEP | JEEP-2605-M4874 | 2026-Q3 | 99.45 | 1.54 | — | Laboratory-retained | 2 | MARGINAL |
| AX-2026-043215 | Afamelanotide | SGN | SGN-2602-Y9898 | 2026-Q3 | 98.92 | 3.40 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043383 | Semaglutide | CPC | CPC-2605-U3098 | 2026-Q3 | 97.63 | 4.29 | 94.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043042 | Retatrutide | KP | KP-2607-H5219 | 2026-Q3 | 96.11 | 5.60 | — | Buyer-sourced | 2 | FAIL |
| AX-2026-041389 | BPC-157 | WWB | WWB-2606-H3906 | 2026-Q3 | 99.58 | 4.69 | — | Supplier-supplied | 1 | MARGINAL |